| Date Filed | Type | Description |
| 10/05/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.2907, valued at
$64.8k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/24/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.9118, valued at
$79.2k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/10/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 14,498 shares
@ $11.0255, valued at
$159.8k
Sold 3,272 shares
@ $11.7468, valued at
$38.4k
|
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/27/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Gifted 14,000 shares
@ $0
Sold 18,719 shares
@ $14.6089, valued at
$273.5k
|
|
| 07/25/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/13/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $6.8873, valued at
$61.2k
|
|
| 07/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/29/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.3876, valued at
$65.6k
|
|
| 06/15/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 15,485 shares
@ $9.9778, valued at
$154.5k
|
|
| 06/01/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.7939, valued at
$78.1k
|
|
| 05/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $5.0918, valued at
$45.2k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/23/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.3994, valued at
$65.7k
|
|
| 03/09/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.3274, valued at
$74k
|
|
| 02/23/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.733, valued at
$68.7k
|
|
| 02/09/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.8084, valued at
$78.3k
|
|
| 01/26/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.7077, valued at
$77.4k
|
|
| 01/12/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.6852, valued at
$68.3k
|
|
| 01/05/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,325 shares
@ $0 |
|
| 12/29/2022 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.2451, valued at
$64.4k
|
|
| 12/15/2022 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.9587, valued at
$79.6k
|
|
| 12/01/2022 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.7547, valued at
$77.8k
|
|
| 11/18/2022 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 17,770 shares
@ $11.1204, valued at
$197.6k
|
|
| 10/05/2022 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 920 shares
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,300 shares
@ $0 |
|
|